Automation index

How much of a Quality engineer’s job can AI already do?

An FMEA and an 8D come earlier. Stopping the supplier and deciding if the batch travels do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

29%

AI can already do 29% of this job.

#63 / 643

Quality engineer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
FMEA, control plan and the limits. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
8D, claims and the supplier. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Audit, IATF and the awkward finding. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
The line, the defect and stop or not. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
APQP, PPAP and the customer launch. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Release with judgement, and not hiding the PPM. Estimate No public source provides a precise figure. This is our estimate.	16%	14%	+2.2
Total	100%		28%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#153 / 643

Hospital pharmacist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Transcription, reconciliation and the error. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Validate, the interaction and the one that cannot. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Chemo, the cabinet and not mixing the batch. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Ward, the doubt and going down to see the patient. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The board, the expensive drug and not yielding to pressure. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Validate the regimen, and not missing the error. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low